UMBC Professor Hopes His New NIH-Funded Research Can Speed up the Drug Approval Process

Published on :

UMBC professor hopes his new NIH-funded research can speed up the drug approval process Email Facebook LinkedIn Twitter Share article
Chengpeng Chen hopes that his research at UMBC can create a more accurate model of how human organs work, making it easier for drug companies in Baltimore and beyond to earn FDA approval.
Courtesy of UMBC
By Matt Hooke – Reporter
October 10, 2022, 07:32am EDT
A University of Maryland, Baltimore County professor hopes to rapidly speed up the drug approval process, making it easier for drugs to get to market and help patients.
In August, Chengpeng Chen earned a five-year, $1.7 million grant from the National Institutes of Health (NIH) to create a new way to model how drugs will impact human organs, starting with the liver. The device would shorten the time it takes to get U.S. Food and Drug Administration approval by providing a more accurate view of how drugs impact the human body than current testing methods. Baltimore is a hub for medical research, with several area pharmaceutical companies, such as MIRA1a Therapeutics and Alphyn Biologics earning substantial funding rounds. A faster way to get through the FDA approval process could be a boon to the…

Maryland Stem Cell Research Commission Announces Over $4 Million in Awards to Accelerate Cures

Published on :

The Maryland Stem Cell Research Commission announced it will grant $4,165,325 in award funding to innovative research that will strengthen and advance stem cell treatments and technologies in Maryland.

NSF Awards $10M To UMBC To Expand Successful Initiative Developing Underrepresented Postdocs In STEM

Published on :

UMBC will expand its work boosting diversity in academia from Maryland to the national level through a new NSF INCLUDES Alliance: Re-Imagining STEM Equity Utilizing Postdoc Pathways (RISE UPP). The RISE UPP Alliance, anticipated to officially launch in fall 2022, is modeled after the AGEP PROMISE Academy, a high-impact initiative co-led by UMBC that supports faculty diversification in the biomedical sciences across University System of Maryland (USM) institutions. 
The UMBC-led RISE UPP Alliance will assist the University of Texas System, Texas A&M University System, and University of North Carolina System in creating programs similar to the AGEP PROMISE Academy, but tailored to meet the needs of their specific institutions and systems. The AGEP PROMISE Academy focuses on recruiting diverse Ph.D. recipients and helping them develop their careers from the postdoc to tenure-track faculty stage. UMBC has received a $10 million grant from the National Science Foundation (NSF) to replicate this national model. 

In Conversation: Mark Schenerman, Graduate Program Director in Biotechnology at UMBC

Published on :

Just recently, UMBC appointed biotech industry veteran Mark Schenerman as Graduate Program Director in Biotechnology, marking an important milestone for the program as it looks to move into a new phase of innovation and growth. Schenerman is an active UMBC biotech professor, runs his own biotech consulting business, and built an impressive biotech career that included more than two decades at MedImmune, one of the most important biotech companies in the region’s history.

UMBC Biotech Master’s Program Equips Professionals with Skills for Success

Published on :

UMBC’s Biotechnology Master’s program provides specialized training that not only teaches students the latest skills and trends in biotech, but equips them to be successful in sought-after management and leadership roles.

Meet Your 2021 BioBuzz Award Winners

Orange banner with photos of people, with text saying "2nd Annual BioBuzz Awards - Presenting Your Winners"
Published on :

Today, we are excited to announce the winners of our 2nd Annual BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.